Rhinosinusitis and aspirin-exacerbated respiratory disease.
about
Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burdenICON: chronic rhinosinusitis.Exploration of the Sphingolipid Metabolite, Sphingosine-1-phosphate and Sphingosine, as Novel Biomarkers for Aspirin-exacerbated Respiratory Disease.Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study.
P2860
Rhinosinusitis and aspirin-exacerbated respiratory disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Rhinosinusitis and aspirin-exacerbated respiratory disease.
@ast
Rhinosinusitis and aspirin-exacerbated respiratory disease.
@en
type
label
Rhinosinusitis and aspirin-exacerbated respiratory disease.
@ast
Rhinosinusitis and aspirin-exacerbated respiratory disease.
@en
prefLabel
Rhinosinusitis and aspirin-exacerbated respiratory disease.
@ast
Rhinosinusitis and aspirin-exacerbated respiratory disease.
@en
P2860
P356
P1433
P1476
Rhinosinusitis and aspirin-exacerbated respiratory disease
@en
P2093
M Alejandro Jimenez-Chobillon
Maria L Garcia Cruz
P2860
P304
P356
10.1155/2012/273752
P50
P577
2012-07-04T00:00:00Z